RecruitingNCT07816692

iDose TR Administration in an Office-Based Surgery Setting

Real-World Evidence Observational Study to Evaluate the Safety of iDose® TR (Travoprost Intracameral Implant) 75 µg in an Office-Based Surgery Setting

Sponsor

Glaukos Corporation

Enrollment

30 participants

Start Date

May 13, 2026

Study Type

OBSERVATIONAL

Conditions

Open-angle Glaucoma (OAG)Ocular Hypertension (OHT)

Summary

Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying iDose TR (travoprost intracameral implant) 75 µg for people with ocular hypertension (oht) and open-angle glaucoma (oag). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.